---
title: Buy Pradaxa (Dabigatran) 150mg Caps Online
description: Pradaxa (Dabigatran) 150mg capsules prevent blood clots and stroke in atrial fibrillation. Secure your supply from our verified online pharmacy with reliable shipping.
type: product
language: en 
url: https://liabilis.com/order-pradaxa-online-en.html
availability: in_stock
shipping:
  - type: Standard Airmail
    price: 10.00
    currency: USD
    area: Worldwide
    time: 14-21 days
  - type: Tracked Express
    price: 30.00
    currency: USD
    area: Worldwide
    tracking: true
    time: 5-9 days
price_min: 91.99
price_max: 642.99
currency: USD
offers:
  - name: 150mg x 10 caps
    price: 91.99
  - name: 150mg x 20 caps
    price: 173.99
  - name: 150mg x 30 caps
    price: 228.99
  - name: 150mg x 60 caps
    price: 439.99
  - name: 150mg x 90 caps
    price: 642.99
---

# Buy Pradaxa (Dabigatran) 150mg Caps Online

Pradaxa, containing Dabigatran and developed by Boehringer Ingelheim, is a direct oral anticoagulant. It reduces the risk of stroke and systemic embolism in non-valvular atrial fibrillation, and treats DVT and PE in adults. Ideal for patients requiring anticoagulation therapy. Get Pradaxa 150mg caps from our online pharmacy.

## Pricing and Options

| Dosage | Pack Size | Price (USD) | Price Per Pill | Status |
| :--- | :--- | :--- | :--- | :--- |
| **150mg** | 10 caps | **$91.99** | $9.20 | In Stock |
| **150mg** | 20 caps | **$173.99** | $8.70 | In Stock |
| **150mg** | 30 caps | **$228.99** | $7.63 | In Stock |
| **150mg** | 60 caps | **$439.99** | $7.33 | In Stock |
| **150mg** | 90 caps | **$642.99** | $7.14 | In Stock |


[Buy Now](https://liabilis.com/order-pradaxa-online-en.html)

## Introduction 
Pradaxa is an oral anticoagulant used to reduce the risk of blood clots that can cause stroke, deep-vein thrombosis (DVT) or pulmonary embolism (PE). The medication contains the active ingredient dabigatran, a direct thrombin inhibitor, and is supplied as a 150 mg capsule. It belongs to the class of novel oral anticoagulants (NOACs). In addition to its primary role in preventing stroke in patients with non-valvular atrial fibrillation, Pradaxa is approved for the treatment and secondary prevention of DVT and PE, as well as for VTE prophylaxis after certain orthopedic surgeries.

## Quick Reference Facts 
**Active Ingredient** 
: dabigatran 

**Form** 
: capsule 150 mg 

**Primary and Off-Label Uses** 
: • Stroke prevention in non-valvular atrial fibrillation 
 • Treatment of DVT and pulmonary embolism 
 • Prevention of recurrent DVT/PE after initial therapy 
 • Post-operative VTE prophylaxis (orthopedic surgery) 
 • Off-label: certain cases of left-atrial appendage closure, pediatric anticoagulation (under specialist supervision)

## What is Pradaxa? 
Pradaxa is a brand-named oral anticoagulant whose active component is dabigatran etexilate. The drug is classified as a direct thrombin inhibitor, a subset of the broader novel oral anticoagulant (NOAC) family. Although Pradaxa is the commercial name, the same chemical entity is available in generic form as dabigatran capsules. Generic alternatives are bioequivalent to Pradaxa, delivering identical plasma concentrations and therapeutic effects at lower cost. The medication is manufactured by Boehringer Ingelheim and has been approved by major regulators, including the U.S. FDA and the European Medicines Agency, for the indications listed above. Because it is a generic-type product, patients can often obtain the same therapeutic benefit at a reduced price compared with the branded version.

## How Pradaxa Works 
Dabigatran, the active compound in Pradaxa, binds directly to thrombin (factor IIa). By inhibiting thrombin, the drug prevents the conversion of fibrinogen to fibrin, a key step in clot formation. Unlike vitamin K antagonists, dabigatran’s effect is focused on a single enzyme, which results in a rapid onset of anticoagulation-usually within 2 hours after oral intake-and a predictable anticoagulant response that does not require routine laboratory monitoring. The drug is absorbed primarily in the gastrointestinal tract and reaches peak plasma concentrations in about 2 hours. About 80 % of dabigatran is eliminated unchanged by the kidneys; the remaining fraction is metabolized by esterases and excreted in the urine and feces. This renal-centric clearance profile explains why dose adjustments are recommended in patients with impaired kidney function.

## Conditions Treated with Pradaxa 
- **Non-valvular atrial fibrillation (NVAF)** - Patients with NVAF are at heightened risk for cardio-embolic stroke. Dabigatran reduces stroke incidence by inhibiting thrombin-mediated clot formation in the atria. 
- **Deep-vein thrombosis (DVT)** - By preventing fibrin generation, the drug limits clot propagation in the deep veins of the lower extremities, facilitating resolution and preventing extension. 
- **Pulmonary embolism (PE)** - In established PE, dabigatran curtails further clot growth and reduces the likelihood of recurrent embolic events. 
- **Secondary prevention of DVT/PE** - After initial treatment, continued anticoagulation with dabigatran lowers the risk of recurrent venous thromboembolism. 
- **Post-operative VTE prophylaxis** - Following hip or knee replacement surgery, dabigatran is used to prevent new clot formation during the high-risk postoperative period.

## Is Pradaxa the Right Medication for You? 
Pradaxa is most appropriate for adult patients who require anticoagulation but prefer a regimen that does not involve routine INR monitoring. It is especially suitable for individuals with non-valvular atrial fibrillation, those treated for an acute DVT or PE, and patients undergoing major orthopedic surgery who need VTE prophylaxis. The drug is contraindicated in patients with active pathological bleeding, severe renal impairment (creatinine clearance < 30 mL/min), or a known hypersensitivity to dabigatran. Caution is advised in older adults, patients with moderate renal dysfunction, and those taking strong P-glycoprotein inhibitors or inducers, as these agents can alter dabigatran plasma levels. Shared decision-making with a healthcare professional is essential to balance stroke prevention benefits against bleeding risk.

## Buying Pradaxa from [our online pharmacy](https://liabilis.com/order-pradaxa-online-en.html) 

### Why Choose Our Service? 
Accessing anticoagulant therapy can be financially burdensome or limited by local pharmacy inventories. [our online pharmacy](https://liabilis.com/order-pradaxa-online-en.html) offers a convenient, cost-effective way to obtain the generic form of dabigatran, ensuring you receive the same therapeutic quality as the branded product without unnecessary expense. 

### Quality & Safety Assurance 
We partner with licensed international pharmacies to ensure quality and authenticity. Every shipment is sourced from manufacturers that comply with Good Manufacturing Practice (GMP) standards and are inspected by regulatory authorities. 

### Pricing & Access 
Because we provide the generic equivalent, pricing is typically close to the manufacturer’s wholesale cost, delivering a significant saving compared with the branded Pradaxa. This model also facilitates access for patients who may encounter insurance coverage gaps or regional shortages. 

### Discreet Delivery 
Orders are packaged in unmarked, secure envelopes and dispatched via express courier (usually within 7 days) or standard airmail (approximately 3 weeks). Your privacy is protected throughout the shipping process, and tracking information is provided for each shipment. 

Through our platform, you can order the 150 mg dabigatran capsules with confidence that the product is genuine, affordable, and delivered discreetly to your doorstep.

## Use: Dosing, Missed Dose, Overdose 

- **Standard dosing** - For most indications, the recommended dose is 150 mg taken orally once daily with or without food. 
- **Renal adjustment** - Patients with creatinine clearance 30-50 mL/min may be prescribed a reduced dose of 110 mg once daily (where available). 
- **Missed dose** - If you forget a dose, take it as soon as you remember **provided it is at least 8 hours before the next scheduled dose**. If it is near the time of the next dose, skip the missed one and continue your regular schedule. Do not double-dose. 
- **Overdose** - Symptoms may include sudden bleeding, severe bruising, or gastrointestinal hemorrhage. Seek emergency medical assistance immediately. Activated charcoal may be considered if ingestion was recent, and idarucizumab (a specific dabigatran reversal agent) is available in many hospitals. 
- **Administration notes** - Dabigatran may be taken with food to improve tolerability, but it does not require fasting. Avoid excessive alcohol, as it can increase bleeding risk. Do not operate heavy machinery or drive until you are confident that the medication does not cause dizziness or visual disturbances.

## Safety Information 

### ⚠️ Who Should Not Take Pradaxa 
- Active pathological bleeding (e.g., gastrointestinal ulcer, intracranial hemorrhage) 
- Severe renal impairment (creatinine clearance < 30 mL/min) 
- Known hypersensitivity to dabigatran or any capsule excipients 
- Patients with mechanical heart valves (dabigatran is contraindicated) 

### Common Side Effects 
- Minor gastrointestinal discomfort (nausea, dyspepsia) - occurs in up to 10 % of users; usually transient 
- Easy bruising or minor bleeding from gums - generally self-limiting 
- Headache - reported infrequently; monitor if persistent 

### Serious Side Effects (Seek Immediate Medical Help) 
- Severe bleeding (e.g., hematuria, melena, hematemesis, intracranial hemorrhage) 
- Allergic reactions (rash, swelling, difficulty breathing) 
- Sudden drop in blood pressure or fainting 

### Drug & Food Interactions 
- **P-glycoprotein inhibitors** (e.g., verapamil, quinidine) - may increase dabigatran levels; dose adjustment may be required. 
- **P-glycoprotein inducers** (e.g., rifampin, carbamazepine) - may reduce efficacy, necessitating closer monitoring. 
- **Antiplatelet agents** (aspirin, clopidogrel) - combined use raises bleeding risk; assess benefit-risk ratio. 
- **NSAIDs** - concurrent use can potentiate gastrointestinal bleeding. 

## Off-Label and Investigational Uses of Pradaxa 
- **Left-atrial appendage closure** - Some clinicians use dabigatran as an alternative anticoagulant after percutaneous closure devices, based on small cohort studies suggesting comparable stroke protection. 
- **Pediatric anticoagulation** - Limited case series have explored dabigatran for children with congenital heart disease; evidence remains preliminary and not regulatory-approved. 
- **Cancer-associated thrombosis** - Emerging trials compare dabigatran to low-molecular-weight heparin for VTE in oncology patients, showing promising efficacy but requiring further validation. 

All off-label applications should be undertaken only under the direct supervision of a qualified healthcare provider, as safety and efficacy have not been formally established by regulatory agencies.

## Storage & Handling 
- **Temperature** - Store capsules at 20-25 °C (68-77 °F); excursions between 15-30 °C are acceptable. 
- **Light & humidity** - Keep the bottle tightly closed, away from direct sunlight and excessive moisture. 
- **Expiry** - Do not use beyond the printed expiration date; discard any capsules that appear discolored or damaged. 
- **Disposal** - Return unused medication to a pharmacy-based take-back program or follow local regulations for hazardous waste disposal.

## Frequently Asked Questions 

**Practical Use & Lifestyle** 

- **Can I travel internationally with Pradaxa?** 
 Yes, the 150 mg capsules are stable at room temperature and can be carried in your hand luggage. Keep them in the original container with a copy of the prescription in case customs officials request documentation. 

- **Will taking Pradaxa affect my ability to exercise?** 
 Moderate activity is generally safe, but high-impact sports that increase injury risk should be discussed with your clinician, as bleeding complications may be more likely. 

- **Is it safe to drink alcohol while on Pradaxa?** 
 Light to moderate alcohol intake does not significantly alter dabigatran levels, but excessive consumption can increase bleeding risk and should be avoided. 

**Product Information** 

- **What do Pradaxa capsules look like?** 
 The 150 mg capsules are pink, oval-shaped, and engraved with the dosage strength on one side. Appearance may vary slightly between manufacturers of the generic version. 

- **Can I split a Pradaxa capsule to adjust the dose?** 
 No. Dabigatran capsules are designed for whole-pill administration; splitting can lead to dose inaccuracy and reduced efficacy. 

**Regulatory & Safety Nuances** 

- **Will Pradaxa show up on a standard drug test?** 
 Routine workplace drug screens do not detect anticoagulants like dabigatran, as they are not substances of abuse. 

- **Is Pradaxa safe for pregnant women?** 
 Dabigatran is classified as pregnancy category C; animal studies show risk, and human data are limited. It should be avoided unless the potential benefit justifies the risk, and only under specialist guidance. 

- **How does kidney function influence Pradaxa use?** 
 Since the drug is primarily excreted unchanged by the kidneys, reduced renal clearance can lead to higher plasma concentrations and increased bleeding risk, necessitating dose reduction or alternative therapy. 

**Scientific & Clinical Curiosity** 

- **What major trial established Pradaxa’s efficacy for stroke prevention?** 
 The RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial demonstrated that dabigatran 150 mg twice daily was non-inferior to warfarin for preventing stroke and systemic embolism in NVAF patients, with lower rates of intracranial hemorrhage. 

- **How does dabigatran differ from other NOACs like rivaroxaban?** 
 Dabigatran directly inhibits thrombin (factor IIa), whereas rivaroxaban targets factor Xa. This difference influences pharmacokinetics, reversal strategies, and specific clinical trial outcomes. 

## Glossary 
**Direct thrombin inhibitor** 
: A class of anticoagulants that bind to the enzyme thrombin, blocking the conversion of fibrinogen to fibrin, the final step in clot formation. 

**Creatinine clearance** 
: An estimate of kidney filtration capacity, expressed in milliliters per minute, used to adjust doses of renally cleared drugs. 

**GMP (Good Manufacturing Practice)** 
: Regulatory standards that ensure pharmaceutical products are consistently produced and controlled according to quality standards. 

## Disclaimer 
The information provided about **Pradaxa** is for general knowledge only. It does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. [our online pharmacy](https://liabilis.com/order-pradaxa-online-en.html) offers access to **Pradaxa** for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.